StemCell Institute Inc. (7096.T)
- Previous Close
1,117.00 - Open
1,114.00 - Bid 1,088.00 x --
- Ask 1,097.00 x --
- Day's Range
1,085.00 - 1,117.00 - 52 Week Range
1,085.00 - 1,923.00 - Volume
53,700 - Avg. Volume
29,701 - Market Cap (intraday)
11.138B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
26.49 - EPS (TTM)
41.33 - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 27, 2024
- 1y Target Est
--
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
www.stemcell.co.jpRecent News: 7096.T
View MorePerformance Overview: 7096.T
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7096.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7096.T
View MoreValuation Measures
Market Cap
11.36B
Enterprise Value
8.52B
Trailing P/E
27.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.33
Price/Book (mrq)
3.96
Enterprise Value/Revenue
3.23
Enterprise Value/EBITDA
14.63
Financial Highlights
Profitability and Income Statement
Profit Margin
14.37%
Return on Assets (ttm)
3.73%
Return on Equity (ttm)
14.48%
Revenue (ttm)
2.68B
Net Income Avi to Common (ttm)
385M
Diluted EPS (ttm)
41.33
Balance Sheet and Cash Flow
Total Cash (mrq)
3.2B
Total Debt/Equity (mrq)
19.67%
Levered Free Cash Flow (ttm)
7.25M